NAD+CAS 64417-72-7, high quality
COA
64417-72-7
Pharmaceutical Grade
99.65%
Qingdao
Million
vials
2039-11-24
Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2
-
Product Description
-
Seller Information
-
DescriptionCertificatesBasic Info
-
Product Name:
Adenosine 5′-(trihydrogen diphosphate), P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium, inner salt, lithium salt (1:1)
Other Name:Adenosine 5′-(trihydrogen diphosphate),P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium,inner salt,lithium salt (1:1);Adenosine 5′-(trihydrogen diphosphate),P′→5′ ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium hydroxide,inner salt,monolithium salt;Adenosine 5′-(trihydrogen diphosphate),P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium,inner salt,monolithium salt;β-NAD monolithium salt
CAS No.:64417-72-7
Molecular Formula:C21H27N7O14P2.Li
InChIKeys:InChIKey=BSBXSNLPTFPMHS-QYZPTAICSA-N
Molecular Weight:669.36
Exact Mass:669.11700
EC Number:264-884-1
Categories:
Characteristics-
PSA:
343.54000
Water Solubility:H2O: 50 mg/mL
Storage Conditions:2-8°C
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2
-
Location:
Room 1-2208, Lianhecaifu Square, No2177, Tianchen Road, Gaoxin District, Jinan City, Shandong Province, China
-
Payment Terms:
L/C,100% TT in advance
-
Average lead Time:
3
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2012
-
Certifications:
business license
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
